Apollon Wealth Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
24,201
+41
| +0.2% | +$191 | ﹤0.01% | 1215 |
|
|
2025
Q1 | $133K | Buy |
24,160
+4,000
| +20% | +$22K | ﹤0.01% | 1132 |
|
|
2024
Q4 | $68.3K | Hold |
20,160
| – | – | ﹤0.01% | 1155 |
|
|
2024
Q3 | $57.5K | Hold |
20,160
| – | – | ﹤0.01% | 1108 |
|
|
2024
Q2 | $45.4K | Hold |
20,160
| – | – | ﹤0.01% | 1074 |
|
|
2024
Q1 | $44.6K | Sell |
20,160
-9
| -0% | -$20 | ﹤0.01% | 1089 |
|
|
2023
Q4 | $47.4K | Buy |
20,169
+9
| +0% | +$21 | ﹤0.01% | 1051 |
|
|
2023
Q3 | $37.5K | Hold |
20,160
| – | – | ﹤0.01% | 890 |
|
|
2023
Q2 | $52.8K | Hold |
20,160
| – | – | ﹤0.01% | 921 |
|
|
2023
Q1 | $32.9K | Hold |
20,160
| – | – | ﹤0.01% | 851 |
|
|
2022
Q4 | $26.8K | Hold |
20,160
| – | – | ﹤0.01% | 837 |
|
|
2022
Q3 | $31K | Hold |
20,160
| – | – | ﹤0.01% | 789 |
|
|
2022
Q2 | $31K | Hold |
20,160
| – | – | ﹤0.01% | 735 |
|
|
2022
Q1 | $52K | Hold |
20,160
| – | – | ﹤0.01% | 736 |
|
|
2021
Q4 | $59K | Hold |
20,160
| – | – | ﹤0.01% | 744 |
|
|
2021
Q3 | $49K | Buy |
+20,160
| New | +$49K | 0.01% | 463 |
|
|
2021
Q2 | – | Sell |
-25,002
| Closed | -$113K | – | 385 |
|
|
2021
Q1 | $113K | Buy |
25,002
+692
| +3% | +$3.13K | 0.02% | 333 |
|
|
2020
Q4 | $120K | Buy |
+24,310
| New | +$120K | 0.03% | 193 |
|